Home » Topics » Science » New compound

New compound
RSS

Potent non-HAP class I HBV capsid assembly modulator ALG-005398 reduces HBsAg levels in vivo

Nov. 22, 2021

Novel STING agonist RVU-27065 shows potency in EMT6 breast cancer model

Nov. 18, 2021

PCC-1, an orally active HPK1 inhibitor with strong antitumor activity

Nov. 18, 2021

Novel pan-ERR agonists can provide cardioprotection against heart failure

Nov. 17, 2021

BAY-56-6544 improves vasomotor function in accelerated-aging model

Nov. 16, 2021

CPI-381: a first-in-class TREX1 inhibitor with antitumor activity in preclinical models

Nov. 16, 2021

LPAR1 antagonist PIPE-791 promotes remyelination in multiple sclerosis

Nov. 15, 2021

Cannabigerol derivatives have anti-inflammatory, analgesic and antiobesity potential

Nov. 12, 2021

Trivalent PROTAC SIM-1 shows enhanced BET degradation and cytotoxicity

Nov. 11, 2021

SUVN-4404091 shows efficacy in rat model of amphetamine-induced hyperlocomotion

Nov. 11, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Researchers hit back after colleagues removed from ADA meeting
BioWorld
Former principal officers of the American Diabetes Association (ADA) have hit back at the association’s board and CEO after it prohibited the distribution of an...